Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma
This completed clinical trial evaluated comprehensive geriatric assessment and laboratory biomarkers in elderly patients with multiple myelo…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating alternate dosing schedules of belantamab mafodotin for triple-class refractory multiple myeloma; recruit…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma [Phase 1, Phase 2]
This document describes an ongoing Phase 1/2 clinical trial to determine the recommended dose and schedule and assess safety and preliminary…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomib + LDD in Triple-class Refractory MM. [Phase 2]
An update on an ongoing Phase 2 trial studying selinexor with low-dose dexamethasone in penta-refractory multiple myeloma, and selinexor wit…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory Myeloma After CD38- and BCMA-Targeted Therapies [Phase 1]
A Phase 1 clinical trial evaluating the combination of Elotuzumab, CC-92480, and Dexamethasone in relapsed or refractory multiple myeloma af…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Expanded Access to Venetoclax
Expanded access to venetoclax is being offered for multiple hematologic cancers, including chronic lymphocytic leukemia, multiple myeloma, A…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM [Phase 1]
This document summarizes a Phase 1 clinical trial update evaluating a DC/MM fusion vaccine in combination with BCMA-targeted CAR-T therapy f…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant [Phase 3]
This clinical trial update describes a Phase 3 study evaluating SCTC21C in combination with bortezomib, lenalidomide and dexamethasone for n…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Effects of Controlled Breathing on Cardiorespiratory Variables in Multiple Myeloma [NA]
A clinical trial from Universidad Complutense de Madrid is studying whether controlled breathing has measurable effects on cardiorespiratory…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM) [Phase 2]
Phase 2 clinical trial evaluating BCMA-targeted bispecific antibody therapy for multiple myeloma patients who relapse after BCMA CAR T-cell …
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of Treatment [NA]
A clinical study evaluating a BCMA-GPRC5D CAR-T therapy for relapsed/refractory multiple myeloma is listed, but the trial is not yet recruit…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics [NA]
This entry reports a recruiting trial at UNC Lineberger Comprehensive Cancer Center evaluating a decision-support tool for adults with hemat…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency [Phase 2]
An ongoing Phase 2 clinical trial is testing induction therapy with bortezomib, isatuximab, cyclophosphamide, and dexamethasone in transplan…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy [Phase 3]
Phase 3 clinical trial evaluating a digital health intervention for self-management and telemonitoring in CAR-T therapy is currently recruit…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Myeloma Registry Platform (MYRIAM)
A clinical trial entry for the Myeloma Registry Platform (MYRIAM) sponsored by iOMEDICO AG, currently recruiting participants with multiple …
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 clinical trial is evaluating O&D-001 Injection for relapsed or refractory multiple myeloma. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating AZD0305 as a monotherapy or in combination with anticancer agents for relapsed/refractory multiple …
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating belantamab mafodotin as both monotherapy and in combination therapy for multiple myeloma, currently re…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Memorial Sloan Kettering Cancer Center is recruiting families for genetic studies of familial lymphoproliferative disorders, including lymph…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Fall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Patients [NA]
A recruiting clinical trial at University Hospital Heidelberg is evaluating fall risk assessment and an exercise intervention (strength and …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma [Phase 2]
This Phase 2 trial update reports a study of elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone for relapsed multipl…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Clinical trial update describing a Bristol-Myers Squibb-sponsored study to perform transgene assay testing on tumor samples from patients wh…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma [NA]
A clinical trial is recruiting for a novel CD19/BCMA dual-targeted CAR-T cell therapy for relapsed/refractory multiple myeloma.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments [Phase 1]
Clinical trial update announcing a Phase 1 study of Linvoseltamab in combination with other cancer treatments for adults with multiple myelo…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma [EARLY_Phase 1]
An early-phase clinical trial evaluating universal CAR-T cells (REVO-UWD-00B) for refractory and relapsed multiple myeloma is currently recr…